|Bid||169.52 x 1100|
|Ask||169.73 x 800|
|Day's range||167.26 - 170.94|
|52-week range||86.88 - 178.64|
|Beta (5Y monthly)||1.08|
|PE ratio (TTM)||40.10|
|Earnings date||03 May 2021 - 07 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||198.00|
The biggest news for Jazz Pharmaceuticals (NASDAQ: JAZZ) in recent months was the company's announcement earlier this month that it plans to acquire GW Pharmaceuticals in a $7.6 billion deal. Now, Jazz has more news that investors eagerly awaited. Here are the highlights from Jazz's Q4 update.
JAZZ earnings call for the period ending December 31, 2020.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentation at the Cowen 41st Annual Healthcare conference.